Agilent acquires Stratagene
Agilent Technologies has announced the acquisition of the company Stratagene, effective as of today.
The takeover is hoped to assist the company in providing more complete workflow solutions in genomics, proteomics and metabolomics.
Stratagene will operate as a division of the company's Life Sciences Solutions unit.
The company has said current customers should expect no change in the way they work with Stratagene and should be able to continue using their existing contact channels.
Air quality expert wins 2025 PM's Prize for Science
Distinguished Professor Lidia Morawska's work in the study of air quality provided vital...
CSL fellowships fund immunity research, AI-designed proteins
Australian scientists Dr Carolien van de Sandt and Dr Rhys Grinter have each been awarded CSL...
Leukaemia Foundation funds ongoing blood cancer research at UWA
The $3m in funding is understood to represent the single largest non-government investment in...
